デフォルト表紙
市場調査レポート
商品コード
1387365

臨床栄養市場レポート:2030年までの動向、予測、競合分析

Clinical Nutrition Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

臨床栄養市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

臨床栄養の動向と予測

世界の臨床栄養市場は、2024年から2030年までのCAGRが8.1%で、2030年までに推定1,109億米ドルに達すると予想されます。この市場の主な促進要因は、代謝性疾患の有病率の上昇と、新興国における中間層の拡大が勢いを増していることです。世界の臨床栄養市場の将来は、がん、神経疾患、消化器疾患、代謝性疾患市場にビジネスチャンスがあり、有望視されています。

臨床栄養市場の洞察

Lucintelは、栄養不良を経験する患者が増加していることから、予測期間中は経口が最大のセグメントであり続けると予測しています。

この市場の中では、慢性疾患を抱える患者の急増が顕著であるため、がんが最大のセグメントであり続けると思われます。

アジア太平洋地域は、医療インフラの整備に多額の投資が行われているため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界の臨床栄養市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の臨床栄養市場の動向(2018-2023)と予測(2024-2030)
  • 投与経路別の世界の臨床栄養市場
    • 経口
    • 経腸
    • 非経口
  • 用途別の世界の臨床栄養市場
    • がん
    • 神経疾患
    • 胃腸障害
    • 代謝障害
    • その他
  • 最終用途別の世界の臨床栄養市場
    • 小児
    • 成人
    • 高齢者
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の臨床栄養市場
  • 北米の臨床栄養市場
  • 欧州の臨床栄養市場
  • アジア太平洋の臨床栄養市場
  • その他地域の臨床栄養市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 投与経路別の世界の臨床栄養市場の成長機会
    • 用途別の世界の臨床栄養市場の成長機会
    • 最終用途別の世界の臨床栄養市場の成長機会
    • 地域別の世界の臨床栄養市場の成長機会
  • 世界の臨床栄養市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の臨床栄養市場の能力拡大
    • 世界の臨床栄養市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Fresenius
  • KGAA
  • Baxter International
  • Abbott Laboratories
  • Lonza
  • B. Braun Melsungen
  • Danone Nutricia
  • Perrigo Company
  • Nestle
  • Hero Nutritionals
目次

Clinical Nutrition Trends and Forecast

The future of the global clinical nutrition market looks promising with opportunities in the cancer, neurological diseases, gastrointestinal disorders, and metabolic disorders markets. The global clinical nutrition market is expected to reach an estimated $110.9 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are escalating prevalence of metabolic disorders and expansion of the middle class in emerging economies is gaining momentum.

A more than 150-page report is developed to help in your business decisions.

Clinical Nutrition by Segment

The study includes a forecast for the global clinical nutrition by route of administration, application, end use, and region.

Clinical Nutrition Market by Route Of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Enteral
  • Parenteral

Clinical Nutrition Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders
  • Others

Clinical Nutrition Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pediatric
  • Adults
  • Geriatric
  • Others

Clinical Nutrition Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Nutrition Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical nutrition companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical nutrition companies profiled in this report include-

  • Fresenius
  • KGAA
  • Baxter International
  • Abbott Laboratories
  • Lonza
  • B. Braun Melsungen
  • Danone Nutricia
  • Perrigo Company
  • Nestle
  • Hero Nutritionals

Clinical Nutrition Market Insights

Lucintel forecasts that oral will remain the largest segment over the forecast period due to growing number of patients are experiencing malnutrition.

Within this market, cancer will remain the largest segment due to surge in individuals with chronic ailments is evident.

APAC is expected to witness highest growth over the forecast period due to significant investments are being made in the development of healthcare infrastructure in the region.

Features of the Global Clinical Nutrition Market

Market Size Estimates: Clinical nutrition market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical nutrition market size by route of administration, application, end use, and region in terms of value ($B).

Regional Analysis: Clinical nutrition market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, applications, end uses, and regions for the clinical nutrition market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical nutrition market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the clinical nutrition market size?

Answer: The global clinical nutrition market is expected to reach an estimated $110.9 billion by 2030.

Q2. What is the growth forecast for clinical nutrition market?

Answer: The global clinical nutrition market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the clinical nutrition market?

Answer: The major drivers for this market are escalating prevalence of metabolic disorders and expansion of the middle class in emerging economies is gaining momentum.

Q4. What are the major segments for clinical nutrition market?

Answer: The future of the clinical nutrition market looks promising with opportunities in the cancer, neurological diseases, gastrointestinal disorders, and metabolic disorders markets.

Q5. Who are the key clinical nutrition market companies?

Answer: Some of the key clinical nutrition companies are as follows:

  • Fresenius
  • KGAA
  • Baxter International
  • Abbott Laboratories
  • Lonza
  • B. Braun Melsungen
  • Danone Nutricia
  • Perrigo Company
  • Nestle
  • Hero Nutritionals

Q6. Which clinical nutrition market segment will be the largest in future?

Answer: Lucintel forecasts that oral will remain the largest segment over the forecast period due to growing number of patients are experiencing malnutrition.

Q7. In clinical nutrition market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to significant investments are being made in the development of healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical nutrition market by route of administration (oral, enteral, and parenteral), application (cancer, neurological diseases, gastrointestinal disorders, metabolic disorders, and others), end use (pediatric, adults, geriatric, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Nutrition Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Nutrition Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Nutrition Market by Route Of Administration
    • 3.3.1: Oral
    • 3.3.2: Enteral
    • 3.3.3: Parenteral
  • 3.4: Global Clinical Nutrition Market by Application
    • 3.4.1: Cancer
    • 3.4.2: Neurological Diseases
    • 3.4.3: Gastrointestinal Disorders
    • 3.4.4: Metabolic Disorders
    • 3.4.5: Others
  • 3.5: Global Clinical Nutrition Market by End Use
    • 3.5.1: Pediatric
    • 3.5.2: Adults
    • 3.5.3: Geriatric
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Nutrition Market by Region
  • 4.2: North American Clinical Nutrition Market
    • 4.2.2: North American Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others
  • 4.3: European Clinical Nutrition Market
    • 4.3.1: European Clinical Nutrition Market by Route Of Administration: Oral, Enteral, and Parenteral
    • 4.3.2: European Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others
  • 4.4: APAC Clinical Nutrition Market
    • 4.4.1: APAC Clinical Nutrition Market by Route Of Administration: Oral, Enteral, and Parenteral
    • 4.4.2: APAC Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others
  • 4.5: ROW Clinical Nutrition Market
    • 4.5.1: ROW Clinical Nutrition Market by Route Of Administration: Oral, Enteral, and Parenteral
    • 4.5.2: ROW Clinical Nutrition Market by Application: Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Nutrition Market by Route Of Administration
    • 6.1.2: Growth Opportunities for the Global Clinical Nutrition Market by Application
    • 6.1.3: Growth Opportunities for the Global Clinical Nutrition Market by End Use
    • 6.1.4: Growth Opportunities for the Global Clinical Nutrition Market by Region
  • 6.2: Emerging Trends in the Global Clinical Nutrition Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Nutrition Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Nutrition Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Fresenius
  • 7.2: KGAA
  • 7.3: Baxter International
  • 7.4: Abbott Laboratories
  • 7.5: Lonza
  • 7.6: B. Braun Melsungen
  • 7.7: Danone Nutricia
  • 7.8: Perrigo Company
  • 7.9: Nestle
  • 7.10: Hero Nutritionals